Trial reportBMC psychiatry2025
Motivation in the Bergen 4-day treatment for obsessive-compulsive disorder.
Trial report in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02656342 (Translational Approach to the Understanding and Treatment of Obsessive-Compulsive Disorder), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Translational Approach to the Understanding and Treatment of Obsessive-Compulsive Disorder (OCD). Can D-Cycloserine Enhance and Stabilize the Treatment-response in Relapsed and Non-responding OCD-patients? A Randomized, Double-blind, Placebo-controlled National Study
Who cites it
2 citing papers in PubMed.
- The Bergen 4-Day OCD Treatment: A Comprehensive Scoping Review of Evidence and Implementation.Acta psychiatrica Scandinavica · 2026Article
- Making Sense of Non-Response: What Patients Teach Us About Concentrated Exposure Therapy for Obsessive Compulsive Disorder.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study investigated the associations among treatment motivation, patient adherence, and treatment outcomes in a group of outpatients with difficult-to-treat obsessive–compulsive disorder (OCD).
methodsA total of 163 relapsed or nonresponding patients were treated with the Bergen 4-day treatment. Motivation was measured with a modified version of the Nijmegen Motivational List 2 (NML2) prior to the start of treatment. During treatment, patients rated their own adherence using the Patient Exposure and Response Prevention (EX/RP) Adherence Scale (PEAS). Treatment outcomes were assessed with the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) at posttreatment and 3-month follow-up.
resultsThe NML2 items related to commitment showed a weak but significant association with treatment outcomes but were not significant when patient adherence was controlled for. Higher adherence was strongly associated with better treatment outcomes. DISCUSSION: Self-reported motivation before the start of treatment had limited predictive validity, whereas in- and between-session patient adherence, which could reflect one aspect of the motivation construct (treatment engagement), was important for recovery.
trial registrationClinicalTrials.gov identifier: NCT02656342 (First registered: 2015–11–30).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.